14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $22.23 $23.98 Wednesday, 24th Apr 2024 EXEL stock ended at $23.71. This is 1.80% more than the trading day before Tuesday, 23rd Apr 2024. During the day the stock fluctuated 2.54% from a day low at $23.19 to a day high of $23.78.
90 days $20.02 $24.07
52 weeks $18.08 $24.34

Historical Exelixis prices

Date Open High Low Close Volume
Feb 12, 2024 $20.24 $20.44 $20.02 $20.39 3 437 528
Feb 09, 2024 $20.30 $20.42 $20.11 $20.22 2 269 146
Feb 08, 2024 $20.18 $20.67 $20.12 $20.17 3 078 642
Feb 07, 2024 $21.09 $21.21 $20.15 $20.18 3 375 190
Feb 06, 2024 $21.36 $21.90 $21.36 $21.83 1 908 528
Feb 05, 2024 $21.29 $21.54 $21.18 $21.40 1 162 283
Feb 02, 2024 $21.75 $21.75 $21.36 $21.49 1 171 086
Feb 01, 2024 $21.75 $21.88 $21.54 $21.75 1 442 866
Jan 31, 2024 $21.93 $22.05 $21.75 $21.76 1 482 263
Jan 30, 2024 $21.97 $22.01 $21.73 $21.89 2 144 015
Jan 29, 2024 $21.89 $22.01 $21.82 $21.89 1 472 250
Jan 26, 2024 $22.30 $22.37 $22.04 $22.12 1 132 057
Jan 25, 2024 $22.14 $22.45 $21.85 $22.09 2 787 275
Jan 24, 2024 $22.61 $22.70 $22.06 $22.11 2 657 751
Jan 23, 2024 $22.60 $22.70 $22.34 $22.61 1 171 369
Jan 22, 2024 $22.50 $22.79 $22.37 $22.64 2 502 884
Jan 19, 2024 $22.29 $22.48 $22.03 $22.48 1 790 405
Jan 18, 2024 $22.47 $22.47 $21.96 $22.27 1 636 778
Jan 17, 2024 $22.49 $22.71 $22.22 $22.54 1 665 724
Jan 16, 2024 $22.60 $22.63 $22.31 $22.54 1 505 768
Jan 12, 2024 $22.59 $22.97 $22.52 $22.70 1 594 892
Jan 11, 2024 $22.68 $22.78 $22.36 $22.41 2 529 164
Jan 10, 2024 $23.38 $23.69 $22.77 $22.86 2 788 570
Jan 09, 2024 $22.70 $23.36 $22.60 $23.27 2 774 805
Jan 08, 2024 $20.36 $22.57 $19.21 $22.54 5 814 558
Click to get the best stock tips daily for free!

About Exelixis

Exelixis Exelixis, Inc., an oncology-focused biotechnology company, focuses on the discovery, development, and commercialization of new medicines to treat cancers in the United States. The company's products include CABOMETYX tablets for the treatment of patients with advanced renal cell carcinoma who received prior anti-angiogenic therapy; and COMETRIQ capsules for the treatment of patients with progressive and metastatic medullary thyroid cancer. Its CA... EXEL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT